![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
Learning 500 Chinese characters in 30 days is possible. |
| Malignant Melanoma |
|
Free Subscription
1 Am J Dermatopathol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Malignant Melanoma is free of charge.
Clinicopathological Study of a Series of Melanomas With IDH1 Mutation.
Am J Dermatopathol. 2026 Mar 27. doi: 10.1097/DAD.0000000000003272.
PubMed
Abstract available
Optimal Follow-Up of Sentinel Node Positive Melanoma Patients?
Ann Surg Oncol. 2026 Mar 30. doi: 10.1245/s10434-026-19547.
PubMed
Circ-ZBTB38 as an oncogenic circular RNA: Mechanisms in disrupting RalGAP
complexes and its clinical value in melanoma.
Biochem Biophys Res Commun. 2026;815:153686.
PubMed
Abstract available
Longitudinal tumor-informed ctDNA monitoring for recurrence and treatment
response in melanoma.
BMC Cancer. 2026 Apr 2. doi: 10.1186/s12885-026-15931.
PubMed
Grand SLAM study protocol: a prospective randomised multicentre study of
shortened versus standard duration adjuvant immune checkpoint inhibition for
stage IIB-C, III and IV cutaneous melanoma.
BMC Cancer. 2026 Mar 27. doi: 10.1186/s12885-026-15924.
PubMed
Descemet membrane endothelial keratoplasty in patients after radiation therapy
for uveal melanoma.
BMC Ophthalmol. 2026;26:161.
PubMed
Melanoma cells release dysfunctional mitochondria to the tumor microenvironment
and circulation in association with tumor progression.
Cancer Lett. 2026;647:218457.
PubMed
Abstract available
A circRNA neoantigen vaccine elicits potent antitumor immunity and synergizes
with checkpoint blockade in melanoma.
Cancer Lett. 2026;648:218459.
PubMed
Abstract available
Large extracellular vesicles regulate endothelial angiogenic potential via
paracrine and autocrine signaling.
J Biol Chem. 2026;302:111193.
PubMed
Abstract available
S100A6 promotes liver metastasis by activating FGFR3 signaling in BAP1-deficient
uveal melanoma.
Oncogene. 2026 Apr 4. doi: 10.1038/s41388-026-03766.
PubMed
Abstract available
Thank you for your interest in scientific medicine.